Classical and non-classical HLA molecules and p16 INK4a expression in precursors lesions and invasive cervical cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 141, Issue 1, 2008, Pages 70-74

  Gonçalves, Maria Alice G ^a   Le Discorde, Magali ^b   Simões, Renata T ^a   Rabreau, Michele ^c   Soares, Edson G ^a   Donadi, Eduardo A ^a   Carosella, Edgardo D ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Inst Univ d'Hématologie   (France)

^c Institut d'Histo Cyto Pathologie   (France)

Author keywords

CIN; HLA A B C E G; HPV; p16 INK4a

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; SKIN DEFECT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; WART VIRUS;

EID: 54949157785     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.06.010     Document Type: Article

References (27)

1. Koller B.H., Geraghty D.E., DeMars R., Duvick L., Rich S.S., and Orr H.T. Chromosomal organization of the human major histocompatibility complex class I gene family. J Exp Med 169 February (2) (1989) 469-480
2. Blaschitz A., Hutter H., and Dohr G. HLA Class I protein expression in the human placenta. Early Pregnancy 5 January (1) (2001) 67-69
3. Crisa L., McMaster M.T., Ishii J.K., Fisher S.J., and Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186 July (2) (1997) 289-298
4. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., and Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64 November (11) (2003) 1039-1044
5. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94 October (21) (1997) 11520-11525
6. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., and Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164 June (12) (2000) 6426-6434
7. Lozano J.M., Gonzalez R., Kindelan J.M., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16 February (3) (2002) 347-351
8. LeMaoult J., Le Discorde M., Rouas-Freiss N., et al. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62 October (4) (2003) 273-284
9. Singer G., Rebmann V., Chen Y.C., et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 9 October (12) (2003) 4460-4464
10. Marin R., Ruiz-Cabello F., Pedrinaci S., et al. Analysis of HLA-E expression in human tumors. Immunogenetics 54 February (11) (2003) 767-775
11. Tomasec P., Braud V.M., Rickards C., et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287 February (5455) (2000) 1031
12. Sheu B.C., Chiou S.H., Chang W.C., et al. Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma. Clin Immunol 115 June (3) (2005) 295-301
13. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 1 (1999) 12-19 [see comments]
14. Liaw K.L., Hildesheim A., Burk R.D., et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183 1 (2001) 8-15
15. O'Brien P.M., and Saveria Campo M. Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res 88 September (1-2) (2002) 103-117
16. van de Putte G., Holm R., Lie A.K., Trope C.G., and Kristensen G.B. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 89 April (1) (2003) 140-147
17. Breitburd F., Ramoz N., Salmon J., and Orth G. HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 7 December (6) (1996) 359-371
18. Hilders C.G., Houbiers J.G., van Ravenswaay Claasen H.H., Veldhuizen R.W., and Fleuren G.J. Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest 69 December (6) (1993) 651-659
19. INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. J Cytochem Histochem 53 4 (2005) 509-516
20. Snijders P.J., van den Brule A.J., Schrijnemakers H.F., Snow G., Meijer C.J., and Walboomers J.M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71 January (Pt 1) (1990) 173-181
21. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M., and Greaves M. (Eds). Molecular diagnostics of human cancer: cancer cells vol. 7 (1989), Cold Spring Harbor Laboratory, New York 209-214
22. Saiki R.K., Gelfand D.H., Stoffel S., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239 January (4839) (1988) 487-491
23. Gonçalves M.A., Soares E.G., Fernandes A.P., et al. Langerhans' cell count and HLA class II profile in cervical intraepithelial neoplasia in the presence or absence of HIV infection. Eur J Obstet Gynecol Reprod Biol 114 2 (2004) 221-227
24. Rieger L., Hofmeister V., Probe C., et al. Th1- and Th2-like cytokine production by first trimester decidual large granular lymphocytes is influenced by HLA-G and HLA-E. Mol Hum Reprod 8 March (3) (2002) 255-261
25. Moreau P., Rousseau P., Rouas-Freiss N., Le Discorde M., Dausset J., and Carosella E.D. HLA-G protein processing and transport to the cell surface. Cell Mol Life Sci 59 September (9) (2002) 1460-1466
26. Moser J.M., Byers A.M., and Lukacher A.E. NK cell receptors in antiviral immunity. Curr Opin Immunol 14 August (4) (2002) 509-516
27. Fernandes A.P., Gonçalves M.A., Duarte G., et al. HPV18, and HIV infection may influence cervical cytokine intralesional levels. Virology 334 April (2) (2005) 294-298